openPR Logo
Press release

Multiplexed Diagnostics Market to Witness Revolutionary Growth

09-15-2021 05:12 AM CET | Health & Medicine

Press release from: Transparancy Market Research

Multiplexed Diagnostics Market

Multiplexed Diagnostics Market

Transparency Market Research (TMR) has published a new report titled, ‘Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1719

Overview

Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic sample for disease diagnosis
Multiplexed diagnostics screen multiple analytes in a single cycle of assay procedure. Though single plex assays are widely available in the market, they fail to yield results for multiple analytes in a single cycle of assay process, and thus when multiple analytes are needed to be screened, cost and turnaround time of single plex assay is higher as compared to multiplexed assay.
Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases is the major factor to drive the global market.
North America dominated the global multiplexed diagnostics market in 2018 and anticipated to dominate during the forecast period.

 Request for Analysis of COVID19 Impact on Multiplexed Diagnostics Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1719

Significant private and public funding for genomics and personalized medicine to Drive Market

Growing demand for automated equipment and multifaceted analytical strategies is the major driver for the growth of global multiplexed diagnostics market.
Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases and Increasing prevalence of cancer and infectious diseases are some of the major factors responsible for the growth of global multiplexed diagnostics market
For instance, as per WHO 2010 data, Breast cancer is one of the most common causes of mortality among females, accounting for 25% of total cancer cases and 15% of cancer mortality across the world (WHO, 2010).
Moreover significant private and public funding for genomics and personalized medicine is also fuelling the growth of global multiplexed diagnostics market.

 Buy Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=1719<ype=S

North America to Dominate Global Market

In terms of region, the global multiplexed diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for major share of the global multiplexed diagnostics market in 2018. Increasing use of multiplexed diagnostics in academic and research institutes, large number of people with oncology and infectious diseases, several market players in the U.S., technological advancements, extensive R&D practices, and increasing awareness about the diagnosis and treatment are likely to boost market growth in the U.S.
For instance, the University of California San Francisco (UCSF) has seven PCR installations for its academic research
The multiplexed diagnostics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be ascribed to growing aging population, high incidence of various diseases, and increased research activities in the region.

Competitive Landscape

The global multiplexed diagnostics market is consolidated as few players hold major market share in global market.
Key players include Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Abbott Laboratories, among others

 Browse more Market Reports:

Insulin Pen Needles Market:

https://www.transparencymarketresearch.com/global-insulin-pen-needles-market.html

Artificial Intelligence in Diabetes Management Market:

https://www.transparencymarketresearch.com/artificial-intelligence-in-diabetes-management-market.html

Body Sensor Market:

https://www.transparencymarketresearch.com/body-sensor-market.html

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplexed Diagnostics Market to Witness Revolutionary Growth here

News-ID: 2393169 • Views: 174

More Releases from Transparancy Market Research

Plasma Feed Market is projected to expand at a high CAGR from 2020 to 2030
Plasma Feed Market: Introduction According to the report, the global plasma feed market was valued at US$ 2.4 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Plasma feed can be defined as feed products, which involve animal-derived plasma proteins and plasma as feed ingredients. Plasma, as an animal feed ingredient, is easily digestible and offers high quality protein. It primarily contains essential plasma proteins, including globulins and
Enteric Disease Testing Market set to witness surge in demand over the forecast …
The size of global enteric disease testing market has exhibited considerable promise for growth in the years to come. Favorable government policies and rapid technological progress are further promoting the growth of the global enteric disease testing market in years to come. In addition, the rising demand for early diagnosis is likely to emerge as another important factor for the market over the period of assessment. Meridian Bioscience, Biomerieux SA, CorisBioconcept SPRL, Alere
Hydroxychloroquine Drugs Market Size to Surge Vigorously during the Forecast Per …
Hydroxychloroquine Drugs Market – Scope of the Report TMR’s report on the global hydroxychloroquine drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global hydroxychloroquine drugs market for the period 2018–2030, considering 2019 as the base year and 2030 as the
Prosthetic Disc Nucleus Market Size will Grow Profitably in the Near Future
Prosthetic Disc Nucleus Market: Introduction According to the report, the global prosthetic disc nucleus market was valued at ~US$ 92 Mn in 2019. It is projected to expand at a moderate CAGR during the forecast period. Prosthetic disc nucleus is hydrogel-based spinal implant used as an adjunct treatment for patients with degenerative disc disorder and herniation, where surgical intervention is the only option. Prosthetic disc nucleus offers an alternative, cost-effective, and minimally invasive procedure to

All 5 Releases


More Releases for Multiplexed

Global Multiplexed Diagnostics Market $12.5 Billion by 2021
According to a market research report Multiplexed Diagnostics Market Analysis and Forecast 2017-2021 published by iHealthcareAnalyst, Inc., the global multiplexed diagnostics market is estimated to reach $12.5 Billion in 2021, expanding at a CAGR of 17.5% from 2017 to 2021. The global multiplexed diagnostics market segmentation is based on technology (low density multiplexed assays, microplate assays, quantitative PCR, medium density multiplexed assays, antibody arrays, bead-based arrays, mass spectrometry, reverse arrays, high
Multiplexed Diagnostics Market to Witness Growth Acceleration During 2024
In a research report recently published by Transparency Market Research, the global multiplexed diagnostics market is expected to witness a high degree of competition over the coming years. This fact is primarily concluded from the high volume of smaller players in the market that are eyed by the fewer, larger ones in terms of partnerships, mergers, and acquisitions. Although the volume of smaller players in the global multiplexed diagnostics market
Multiplexed Diagnostics Market Growth Opportunities and Forecast up to 2024
In a research report recently published by Transparency Market Research, the global multiplexed diagnostics market is expected to witness a high degree of competition over the coming years. This fact is primarily concluded from the high volume of smaller players in the market that are eyed by the fewer, larger ones in terms of partnerships, mergers, and acquisitions. Although the volume of smaller players in the global multiplexed diagnostics market
Multiplexed Diagnostics Market 2017 Specifications and Applications Analysis
Summary: Latest Research Report “Global Multiplexed Diagnostics Market” Added by Orbis Research which covers Market Overview, Product Specification, Profit, Production, Capacity Utilization, Supply, Manufacturing Process & Cost Structure for Different Regions. 2017 Market Research Report on Multiplexed Diagnostics Industry was a professional and depth research report on Multiplexed Diagnostics industry that you would know the world's major regional market conditions of Multiplexed Diagnostics industry, the main region including North American, Europe and
Multiplexed Diagnostics Market: New Business Opportunities & Investment Research …
Global Multiplexed Diagnostics Market: Scope of the Study Based on technology type, the market has been segmented into Very high density multiplexed assays, High density multiplexed assays, Medium density multiplexed assays, Low density multiplexed assays, and Next generation sequencing assays. High density multiplexed assays and medium density multiplexed assays are projected to be lucrative segments of the multiplexed diagnostics market, due to increasing demand in academic research institutes and pharmaceutical companies.
Multiplexed Diagnostics Market 2024 - Analysis and Trends
Global Multiplexed Diagnostics Market: Snapshot The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify